Search

Displaying results 3271 - 3280 of 5925 in total
  1. Drug

    Fenclofenac

    go.drugbank.com/drugs/DB21391
    Experimental

    Fenclofenac has a monoisotopic molecular weight of 296.0 Da.

  2. Drug

    Pirinidazole

    go.drugbank.com/drugs/DB21413
    Experimental

    Pirinidazole has a monoisotopic molecular weight of 250.05 Da.

  3. Drug

    Tifurac

    go.drugbank.com/drugs/DB21415
    Experimental

    Tifurac has a monoisotopic molecular weight of 326.06 Da.

  4. Drug

    Pilavapadin

    go.drugbank.com/drugs/DB21552
    Investigational

    Pilavapadin has a monoisotopic molecular weight of 385.18 Da.

  5. Drug

    Canocapavir

    go.drugbank.com/drugs/DB21570
    Experimental

    Canocapavir has a monoisotopic molecular weight of 561.08 Da.

  6. Drug

    Emzeltrectinib

    go.drugbank.com/drugs/DB21605
    Experimental

    Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da.

  7. Drug

    Zavondemstat

    go.drugbank.com/drugs/DB21608
    Experimental

    Zavondemstat has a monoisotopic molecular weight of 431.22 Da.

  8. Drug

    Loncastuximab tesirine

    go.drugbank.com/drugs/DB16222
    ApprovedInvestigational

    Zylonta also received approval in the EU on December 22, 2022.

    Categories: P-glycoprotein substrates, Cytochrome P-450 Substrates
  9. Drug

    Bufexamac

    go.drugbank.com/drugs/DB13346
    ApprovedWithdrawn

    The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822].

    Synonyms: 2-(p-Butoxyphenyl)-acetohydroxamic acid, p-Butoxyphenylacetohydroxamic acid
  10. Drug

    Etretinate

    go.drugbank.com/drugs/DB00926
    ApprovedWithdrawn

    Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.